Literature DB >> 1161952

Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders.

H M Praag, J Korf, T Schut.   

Abstract

The probenecid technique was used in study of the central dopamine DA metabolism in patients with depressions, psychotic disorders, and Parkinson's disease. The disturbances found were neither nosologically nor syndromally specific, but appeared to be symptom-specific. Decreased DA turnover was associated with hypomotility, and increased DA turnover with hypermotility. Decreased DA turnover was probably related aetiologically to the hypomotility: the symptoms subsided after replenishment of the DA deficiency. The relation between increased DA turnover and hypermotility is still under investigation. In view of the findings obtained, a plea is made for the development of a functional psychopathology, in which psychiatric syndromes are "dissected" into their constituent psychological dysfunctions. This development is expected to stimulate human brain and behaviour research. It can be achieved only by intensive collaboration between psychiatrists and experimental psychologists.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1161952     DOI: 10.1017/s0033291700056385

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  9 in total

Review 1.  The dimensional approach to clinical psychopharmacology: a polysemous concept.

Authors:  P Baruch; M J Filteau; R H Bouchard; E Pourcher; P Vincent; R Jouvent
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

Review 2.  [Syndromal versus nosological diagnosis].

Authors:  M Jäger; K Frasch; T Becker
Journal:  Nervenarzt       Date:  2013-09       Impact factor: 1.214

3.  Motivational deficits after brain injury: effects of bromocriptine in 11 patients.

Authors:  J H Powell; S al-Adawi; J Morgan; R J Greenwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

4.  Electroconvulsive therapy in Parkinson's syndrome with "on-off" phenomenon.

Authors:  J Balldin; S Edén; A K Granérus; K Modigh; A Svanborg; J Wålinder; L Wallin
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

Review 5.  Dysfunctional Heteroreceptor Complexes as Novel Targets for the Treatment of Major Depressive and Anxiety Disorders.

Authors:  Miguel Pérez de la Mora; Dasiel O Borroto-Escuela; Minerva Crespo-Ramírez; José Del Carmen Rejón-Orantes; Daniel Alejandro Palacios-Lagunas; Magda K Martínez-Mata; Daniela Sánchez-Luna; Emiliano Tesoro-Cruz; Kjell Fuxe
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

6.  Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression.

Authors:  C M Banki; G Molnar; I Fekete
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1981

7.  Evidence for a probenecid-sensitive transport system of acid monoamine metabolites from the spinal subarachnoid space.

Authors:  F W Van der Poel; H M Van Praag; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

8.  Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.

Authors:  B Angrist; J Rotrosen; S Gershon
Journal:  Psychopharmacology (Berl)       Date:  1980-01       Impact factor: 4.530

Review 9.  Of mice and men: modelling post-stroke depression experimentally.

Authors:  G Kronenberg; K Gertz; A Heinz; M Endres
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.